文献速递血管炎

抗中性粒细胞胞质抗体(ANCA)滴度的诊断意义:一项回顾性病例对照研究

Diagnostic significance of antineutrophil cytoplasmic antibody (ANCA) titres: a retrospective case-control study.
PubMed 文献 · RMD Open · 2023-01-01

该回顾性观察性单中心研究纳入8年间MPO-ANCA和/或PR3-ANCA免疫测定阳性的288例患者,其中49例为AAV。区分AAV与模仿者的AUC为0.83,最佳阈值为65 U/mL,阴性预测值0.98;多变量分析显示ANCA滴度≥65 U/mL与AAV独立相关(OR 34.21)。

要点

  • ANCA滴度区分AAV与模仿者的AUC为0.83(95%CI 0.79至0.87),最佳阈值为65 U/mL。
  • ANCA滴度≥65 U/mL与AAV独立相关,OR为34.21(95%CI 9.08至129.81;p<0.001)。
  • 其他独立相关因素包括肺纤维化、典型耳鼻喉受累和蛋白尿。

核心结论

  • 高PR3/MPO-ANCA滴度有助于在表现为小血管炎的患者中区分AAV与其模仿者,阈值为65 U/mL及以上。

研究设计与样本

  • 回顾性观察性单中心研究,纳入2010年1月至2018年12月8年间MPO-ANCA和/或PR3-ANCA免疫测定阳性的18岁以上患者,通过电子病历资料。
  • 患者根据2022年ACR/EULAR标准分类,替代诊断分为非AAV自身免疫性疾病(ANCA-AI)和无自身免疫特征的疾病(ANCA-O)。
  • 共纳入288例ANCA阳性患者,其中49例为AAV,ANCA-AI组99例,ANCA-O组140例。

主要发现

  • ANCA-AI组(n=99)与ANCA-O组(n=140)之间无差异。
  • ANCA滴度区分AAV与模仿者的AUC为0.83(95%CI 0.79至0.87)。
  • 无论PR3-ANCA或MPO-ANCA,最佳阈值滴度为65 U/mL,阴性预测值为0.98(95%CI 0.95至1.00)。
  • 多变量分析中,ANCA滴度≥65 U/mL与AAV独立相关,OR为34.21(95%CI 9.08至129.81;p<0.001)。
  • 其他风险因素包括:肺纤维化(OR 11.55,95%CI 3.87至34.47,p<0.001)、典型耳鼻喉受累(OR 5.67,95%CI 1.64至19.67;p=0.006)和蛋白尿(OR 6.56,95%CI 2.56至16.81;p<0.001)。

关键数值与推荐

  • 区分AAV与模仿者的ANCA滴度最佳阈值为65 U/mL,阴性预测值0.98(95%CI 0.95至1.00)。
  • ANCA滴度≥65 U/mL与AAV独立相关,OR 34.21(95%CI 9.08至129.81;p<0.001)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To investigate the reliability of elevated titres of antineutrophil cytoplasmic antibody (ANCA) and to identify a cut-off titre in discriminating between ANCA-associated vasculitides (AAV) and its mimickers. METHODS: This retrospective observational single-centre study included patients over 18 years with positive myeloperoxidase (MPO)-ANCA and/or proteinase 3 (PR3)-ANCA immunoassays over an 8-year period (January 2010 to December 2018), via their electronic medical files. Patients were classified according to the 2022 ACR/EULAR criteria and alternative diagnoses categorised either as non-AAV autoimmune disorders (ANCA-AI) or disorders without autoimmune features (ANCA-O). Findings from the AAV group were compared with those of ANCA-AI and ANCA-O groups and followed by a multivariate logistic stepwise regression analysis of features associated with AAV. RESULTS: 288 ANCA-positive patients of which 49 had AAV were altogether included. There was no difference between patients between the ANCA-AI (n=99) and the ANCA-O (n=140) groups. The AUC for titres discriminating AAV from mimickers was 0.83 (95% CI, 0.79 to 0.87). The best threshold titre, irrespective of PR3-ANCA or MPO-ANCA, was 65 U/mL with a negative predictive value of 0.98 (95% CI, 0.95 to 1.00). On multivariate analysis, an ANCA titre ≥65 U/mL was independently associated with AAV with an OR of 34.21 (95% CI 9.08 to 129.81; p<0.001). Other risk factors were: pulmonary fibrosis (OR, 11.55 (95% CI, 3.87 to 34.47, p<0.001)), typical ear nose and throat involvement (OR, 5.67 (95% CI, 1.64 to 19.67); p=0.006) and proteinuria (OR, 6.56 (95% CI, 2.56 to 16.81; p<0.001)). CONCLUSION: High PR3/MPO-ANCA titres can help to discriminate between AAV and their mimickers in patients presenting with small-calibre vasculitides, with a threshold titre of 65 U/mL and above.

来源:RMD Open,查看原文。版权归原作者所有。

引用

  1. Merindol J, Levraut M, Seitz-Polski B, et al. Diagnostic significance of antineutrophil cytoplasmic antibody (ANCA) titres: a retrospective case-control study. RMD Open. 2023. PMID: 37055171. doi:10.1136/rmdopen-2023-003113

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。